Table 3.
Univariate and multivariate Cox regression analyses of various prognostic parameters in the OS of patients with breast cancer
| Prognostic parameter | Univariate analysis | Multivariate analysis | ||||||
|---|---|---|---|---|---|---|---|---|
| HR | P | 95.0 CI | HR | P | 95.0 CI | |||
| Lower limit | Upper limit | Lower limit | Upper limit | |||||
| FLI‐1 (high vs low) | 35.181 | .000 | 10.548 | 117.347 | 30.486 | .000 | 8.679 | 107.086 |
| Age (≥60 y vs <60 y) | 2.21 | .034 | 1.063 | 4.574 | 2.714 | .075 | 1.135 | 6.491 |
| Lymph node metastasis (yes vs no) | 3.112 | .005 | 1.417 | 6.838 | 1.170 | .799 | 0.349 | 3.920 |
| AJCC stage | .008 | .728 | ||||||
| II stage vs I stage | 1.735 | .409 | 0.470 | 6.409 | 1.861 | .426 | 0.404 | 8.584 |
| III stage vs I stage | 4.719 | .013 | 1.382 | 16.114 | 1.680 | .547 | 0.311 | 9.074 |
| Molecular subtype vs luminal A type | .011 | .167 | ||||||
| Luminal B type | 1.303 | .685 | 0.363 | 4.669 | 1.151 | .841 | 0.292 | 4.531 |
| HER2 positive type | 4.843 | .003 | 1.680 | 13.960 | 2.823 | .075 | 0.900 | 8.857 |
| TNBC type | 2.911 | .014 | 1.236 | 6.854 | 2.599 | .061 | 0.959 | 7.047 |